Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Kimura

Showing results (11-20 of 365) with videos related to

Pageof 37
Sort By:
International Journal of Molecular Sciences|January 28, 2026
Enhancing the Water Solubility and Efficacy of Anticancer Drugs Using Hydroxypropyl-β-CyclodextrinYasushi Kubota, Shinya Kimura
Thrombosis and Haemostasis|March 1, 2005
Molecular mechanism of dysfunctional factor VII associated with the homozygous missense mutation 331Gly to SerOsamu Takamiya, Shinya Kimura
Expert Review of Anticancer Therapy|September 2, 2008
Abl tyrosine kinase inhibitors for overriding Bcr-Abl/T315I: from the second to third generationRuriko Tanaka, Shinya Kimura
Expert Review of Hematology|January 7, 2026
Specifically targeting the ABL myristoyl pocket: STAMP inhibitors for chronic myeloid leukemiaHiroshi Ureshino, Shinya Kimura
Clinical Lymphoma, Myeloma & Leukemia|November 7, 2024
Efficacy and Safety of the First-in-Class STAMP-Inhibitor Asciminib in Patients With Chronic Myeloid LeukemiaHiroshi Ureshino, Shinya Kimura
Chemistryopen|October 20, 2018
Construction of the Pentacyclic Core and Formal Total Synthesis of (<i>rac</i>)-Renieramycin TShinya Kimura, Naoki Saito
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2015
[Immune defects in multiple myeloma]Takero Shindo, Shinya Kimura
Chemistryopen|October 11, 2018
Construction of the Pentacyclic Core and Formal Total Synthesis of (<i>rac</i>)-Renieramycin TShinya Kimura, Naoki Saito
Analytical Chemistry Insights|August 8, 2009
NS-187 (INNO-406), a Bcr-Abl/Lyn dual tyrosine kinase inhibitorTomoko Niwa, Tetsuo Asaki, Shinya Kimura
Clinical Lymphoma, Myeloma & Leukemia|August 10, 2020
Surrogate Markers for Treatment-Free Remission in Patients With Chronic Myeloid LeukemiaHiroshi Ureshino, Kazuharu Kamachi, Shinya Kimura
Pageof 37

Showing results (11-20 of 365) with videos related to

Sort By:
Pageof 37
International Journal of Molecular Sciences|January 28, 2026
Enhancing the Water Solubility and Efficacy of Anticancer Drugs Using Hydroxypropyl-β-CyclodextrinYasushi Kubota, Shinya Kimura
Thrombosis and Haemostasis|March 1, 2005
Molecular mechanism of dysfunctional factor VII associated with the homozygous missense mutation 331Gly to SerOsamu Takamiya, Shinya Kimura
Expert Review of Anticancer Therapy|September 2, 2008
Abl tyrosine kinase inhibitors for overriding Bcr-Abl/T315I: from the second to third generationRuriko Tanaka, Shinya Kimura
Expert Review of Hematology|January 7, 2026
Specifically targeting the ABL myristoyl pocket: STAMP inhibitors for chronic myeloid leukemiaHiroshi Ureshino, Shinya Kimura
Clinical Lymphoma, Myeloma & Leukemia|November 7, 2024
Efficacy and Safety of the First-in-Class STAMP-Inhibitor Asciminib in Patients With Chronic Myeloid LeukemiaHiroshi Ureshino, Shinya Kimura
Chemistryopen|October 20, 2018
Construction of the Pentacyclic Core and Formal Total Synthesis of (<i>rac</i>)-Renieramycin TShinya Kimura, Naoki Saito
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2015
[Immune defects in multiple myeloma]Takero Shindo, Shinya Kimura
Chemistryopen|October 11, 2018
Construction of the Pentacyclic Core and Formal Total Synthesis of (<i>rac</i>)-Renieramycin TShinya Kimura, Naoki Saito
Analytical Chemistry Insights|August 8, 2009
NS-187 (INNO-406), a Bcr-Abl/Lyn dual tyrosine kinase inhibitorTomoko Niwa, Tetsuo Asaki, Shinya Kimura
Clinical Lymphoma, Myeloma & Leukemia|August 10, 2020
Surrogate Markers for Treatment-Free Remission in Patients With Chronic Myeloid LeukemiaHiroshi Ureshino, Kazuharu Kamachi, Shinya Kimura
Pageof 37